Tomosynthesis reduces breast screening recall rates

Tomosynthesis is effective at reducing recall rates in breast cancer screening, according to a new study published online in Radiology.

In the study, Brian Haas, M.D., and Liane Philpotts from the Yale School of Medicine, along with other colleagues, compared recall and cancer detection rates in two groups of women: those receiving digital mammography alone and those who underwent tomosynthesis, as well as mammography.

The cancer detection rate was 5.7 per 1,000 in patients receiving tomosynthesis, compared with 5.2 per 1,000 in patients receiving mammography alone. The addition of tomosynthesis resulted in a 30 percent reduction in the overall recall rate, from 12.0 percent for mammography alone to 8.4 percent in the tomosynthesis group.

"All age groups and breast densities had reduced risk for recall in the tomosynthesis group," Haas said. "Women with dense breasts and those younger than age 50 particularly benefited from tomosynthesis." He added that fewer recalls reduces cost as well as patient anxiety. Announcement

Suggested Articles

Signify Health, a technology company that supports in-home care announced plans to merge with Remedy Partners, a software company that collaborates with…

There are big changes coming to the pharmacy industry and the traditional industry players will need to innovate and pivot to health and wellness to stay ahead.

An assessment looking at 12 health systems that allow patients to download their health records to their smartphones via APIs finds modest uptake.